This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| GenomeTrakr | |
|---|---|
| Name | GenomeTrakr |
| Type | Surveillance network |
| Established | 2012 |
| Country | United States |
| Operating agency | U.S. Food and Drug Administration |
| Purpose | Whole genome sequencing for pathogen surveillance |
GenomeTrakr GenomeTrakr is a distributed whole genome sequencing network used for pathogen surveillance and outbreak investigation. It links laboratory sequencing data across multiple agencies to enable rapid identification of foodborne and clinical isolates. The network integrates sequencing platforms, bioinformatics pipelines, and public databases to support public health, regulatory action, and research.
GenomeTrakr operates as a coordinated sequencing and data-sharing initiative connecting federal laboratories, state public health laboratories, university centers, and international collaborators such as Centers for Disease Control and Prevention, U.S. Food and Drug Administration, United States Department of Agriculture, Public Health Agency of Canada, and European Centre for Disease Prevention and Control. The network emphasizes standardized Illumina sequencing protocols, quality metrics, and open data deposition into repositories like National Center for Biotechnology Information and Sequence Read Archive, enabling downstream use by investigators at Johns Hopkins University, Harvard University, Stanford University, University of California, Davis, and other institutions.
GenomeTrakr originated from initiatives led by the U.S. Food and Drug Administration in collaboration with the Centers for Disease Control and Prevention and the United States Department of Agriculture following technological advances from groups at Broad Institute, Sanger Institute, and National Institutes of Health. Early pilot projects drew on sequencing workflows developed at Rocky Mountain Laboratories, Yale School of Public Health, and state laboratories such as the California Department of Public Health and New York State Department of Health. Expansion coincided with the adoption of next-generation sequencing in outbreak response after notable events involving Listeria monocytogenes, Salmonella enterica, Escherichia coli O157:H7, and other pathogens that impacted stakeholders including Walmart, Chipotle Mexican Grill, and Trader Joe's.
GenomeTrakr standardizes laboratory methods using instruments from manufacturers such as Illumina, Oxford Nanopore Technologies, and associated reagents from companies like Qiagen. Samples undergo DNA extraction protocols in facilities modeled on workflows from Centers for Disease Control and Prevention reference labs and sequenced with short-read and long-read platforms. Data processing uses open-source software such as SPAdes, BWA, SAMtools, FreeBayes, and clustering tools akin to those used in studies at Wellcome Sanger Institute and European Molecular Biology Laboratory. Bioinformatic pipelines align to reference genomes deposited in National Center for Biotechnology Information and apply quality control metrics comparable to standards at Food and Agriculture Organization and World Health Organization networks.
Participating laboratories submit raw reads and assembled genomes to public repositories like National Center for Biotechnology Information and Sequence Read Archive, enabling cross-referencing with databases curated by Centers for Disease Control and Prevention and international partners including Public Health Agency of Canada and European Centre for Disease Prevention and Control. Data-sharing agreements and memorandum of understandings mirror frameworks used by organizations such as Global Microbial Identifier and International Society for Infectious Diseases, balancing open science principles championed by National Institutes of Health and privacy considerations raised by entities like Department of Health and Human Services and Office of the National Coordinator for Health Information Technology.
GenomeTrakr supports outbreak detection and source attribution for foodborne pathogens implicated in recalls involving companies such as PepsiCo, Tyson Foods, Kraft Foods, and products linked to incidents traced to suppliers. Public health responses coordinated with Centers for Disease Control and Prevention and state health departments have used GenomeTrakr data to resolve clusters of Salmonella, Listeria, Escherichia coli, and Campylobacter infections, aiding recalls enforced by the Food and Drug Administration and United States Department of Agriculture. Research institutions including University of Oxford, University of Cambridge, Massachusetts Institute of Technology, and University of Michigan have applied GenomeTrakr datasets to study pathogen evolution, antimicrobial resistance associated with genes like mcr-1, and transmission dynamics explored in collaborations with Bill & Melinda Gates Foundation and Wellcome Trust funded projects.
Governance structures involve leadership from the U.S. Food and Drug Administration in coordination with the Centers for Disease Control and Prevention, state public health labs, and academic partners such as University of California, Davis and Iowa State University. Funding has come from federal appropriations, interagency agreements with United States Department of Agriculture, grants from National Institutes of Health, and cooperative agreements with state laboratories. Partnerships extend to international agencies including Public Health Agency of Canada, World Health Organization, and private-sector contributors like Illumina and contract research organizations collaborating in public–private arrangements.
Critiques of the network echo concerns raised in debates involving World Health Organization and National Institutes of Health about genomic data sharing, including issues of metadata completeness, laboratory capacity disparities between states such as California and Alaska, and interpretive challenges noted by researchers at Johns Hopkins University and Harvard School of Public Health. Limitations include variable sequencing depth, bioinformatics heterogeneity across sites like CDC regional laboratories, potential legal implications involving agencies such as Department of Justice when genomic evidence is used in enforcement actions, and resource constraints highlighted by public health budgets debated in forums including United States Congress and Government Accountability Office reviews.
Category:Public health databases